Noah Gold is a Research Coordinator at the Center for Psychedelic Medicine, where he has been working since 2021 on a number of clinical trials, particularly on two large trials of psilocybin-assisted therapy for alcohol use disorder, and a trial of cannabidiol (CBD) for AUD. He is very interested in the therapeutic potential of psychedelic medicine for a variety of psychological and neurological disorders. He graduated from Tulane University, and will be starting medical school in the fall of 2023.